⌘K

Login Start Free

Home/Filings/4/0001493152-22-007931

4//SEC Filing

Ross Douglas T. 4

Accession 0001493152-22-007931

CIK 0001642380other

View on SEC.gov Company Profile

Filed

Mar 27, 8:00 PM ET

Accepted

Mar 28, 8:00 PM ET

Size

4.6 KB

Accession

0001493152-22-007931

Insider Transaction Report

Form 4

Period: 2022-03-25

Oncocyte CorpOCX

Ross Douglas T.

CMO

Transactions

Purchase
Common Stock, no par value
2022-03-25$1.40/sh+15,000$21,000→ 20,317 total

Documents

1 file

4
ownership.xmlPrimary

Issuer

Oncocyte Corp

CIK 0001642380

Entity typeother

Related Parties

1

filerCIK 0001808413

Filing Metadata

Form type: 4
Filed: Mar 27, 8:00 PM ET
Accepted: Mar 28, 8:00 PM ET
Size: 4.6 KB

View on SEC.gov